Geoff Meacham
Bank of America
Thomas Shrader, PhD, CFA
BTIG
Judah C. Frommer, CFA
Credit Suisse
Andrew S. Fein
H.C. Wainwright
Paul Matteis
Stifel
Colin Bristow
UBS

Acumen Pharmaceuticals, Inc is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Acumen Pharmaceuticals, Inc's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Acumen Pharmaceuticals, Inc or its management. Acumen Pharmaceuticals, Inc does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.